Researchers led by Professor Ting Mei (Northwestern Polytechnical University) and Professors Xiaocong Yuan & Yuquan Zhang ...
A rolling NDA has been initiated for tinlarebant in STGD1, potentially positioning the first disease-modifying systemic ...
Have you ever wished to drive microscopic matter along an arbitrarily tailored trajectory instead of just a circle? That's ...
Scientists have unveiled a breakthrough imaging method that can capture the hidden details of events unfolding in trillionths ...
A novel imaging method captures ultrafast events with unprecedented detail by combining laser encoding and AI reconstruction. Researchers have introduced a new imaging method that reveals far more ...
The full study, “MIF‑Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant Across Central Nervous System Disorders,” is available online in Cancer ...
FB301 was safe and well tolerated in healthy female subjects, with all primary and secondary endpoints metClinically meaningful microbiome ...
The Phase II trial enrolled 129 participants, of whom 94% had relapsing remitting multiple sclerosis, and 6% had secondary ...
13h
Sionna Insider Sells $2.5 Million in Stock Amid 215% Surge, but Here's What Investors Should Watch
This biotech innovator in cystic fibrosis therapies reported a notable insider sale amid a year of standout stock performance ...
Enrollment concludes with just over 60 patients participating across seven clinical sites located throughout the United States VANCOUVER, Washington, April 21, 2026 (GLOBE NEWSWIRE) -- CytoDyn Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results